These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 18614417

  • 1. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU, Okor RS.
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [Abstract] [Full Text] [Related]

  • 2. Potential of carnuba wax in ameliorating brittle fracture during tableting.
    Uhumwangho MU, Okor RS, Adogah JT.
    Pak J Pharm Sci; 2009 Jan; 22(1):58-61. PubMed ID: 19168422
    [Abstract] [Full Text] [Related]

  • 3. Multi-unit dosage formulations of theophylline for controlled release applications.
    Uhumwangho MU, Okor RS.
    Acta Pol Pharm; 2007 Jan; 64(6):553-9. PubMed ID: 18323251
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU, Okor RS.
    Acta Pol Pharm; 2007 Jan; 64(1):73-9. PubMed ID: 17665854
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T, Kanbe H, Okada M, Kawase I, Ikeda Y, Onuki Y, Kaneko T, Sonobe T.
    Int J Pharm; 2007 Aug 16; 341(1-2):105-13. PubMed ID: 17512147
    [Abstract] [Full Text] [Related]

  • 6. Studies on the compressibility of wax matrix granules of acetaminophen and their admixtures with various tableting bases.
    Uhumwangho MU, Okor RS.
    Pak J Pharm Sci; 2006 Apr 16; 19(2):103-7. PubMed ID: 16751119
    [Abstract] [Full Text] [Related]

  • 7. Modification of drug release from acetaminophen granules by melt granulation technique - consideration of release kinetics.
    Uhumwangho MU, Okor RS.
    Pak J Pharm Sci; 2006 Jan 16; 19(1):22-7. PubMed ID: 16632448
    [Abstract] [Full Text] [Related]

  • 8. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep 16; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 9. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics.
    Cheboyina S, Wyandt CM.
    Int J Pharm; 2008 Jul 09; 359(1-2):158-66. PubMed ID: 18499369
    [Abstract] [Full Text] [Related]

  • 10. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
    Alsarra IA, El-Bagory I, Bayomi MA.
    Drug Dev Ind Pharm; 2005 May 09; 31(4-5):385-95. PubMed ID: 16093204
    [Abstract] [Full Text] [Related]

  • 11. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T, Kanbe H, Okada M, Suzuki M, Ikeda Y, Onuki Y, Kaneko T, Sonobe T.
    Int J Pharm; 2005 Nov 04; 304(1-2):91-101. PubMed ID: 16154302
    [Abstract] [Full Text] [Related]

  • 12. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A, Cirri M, Maestrelli F, Corti G, Mura P.
    Farmaco; 2005 Nov 04; 60(11-12):913-8. PubMed ID: 16129436
    [Abstract] [Full Text] [Related]

  • 13. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I, Ferrero C, Jiménez-Castellanos MR.
    Eur J Pharm Biopharm; 2008 May 04; 69(1):285-93. PubMed ID: 17997292
    [Abstract] [Full Text] [Related]

  • 14. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
    Tabasi SH, Moolchandani V, Fahmy R, Hoag SW.
    Int J Pharm; 2009 Dec 01; 382(1-2):1-6. PubMed ID: 19660535
    [Abstract] [Full Text] [Related]

  • 15. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825
    [Abstract] [Full Text] [Related]

  • 16. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA, Al-Hanbali OA, Kanaan RA, Shakya AK, Maraqa A.
    Acta Pol Pharm; 2010 Dec 01; 67(1):93-7. PubMed ID: 20210085
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA, Ferrero C, Jiménez-Castellanos MR.
    Eur J Pharm Biopharm; 2012 Apr 01; 80(3):674-81. PubMed ID: 22210473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.